MX2011006562A - Metodo para elaborar liposomas pequeños. - Google Patents
Metodo para elaborar liposomas pequeños.Info
- Publication number
- MX2011006562A MX2011006562A MX2011006562A MX2011006562A MX2011006562A MX 2011006562 A MX2011006562 A MX 2011006562A MX 2011006562 A MX2011006562 A MX 2011006562A MX 2011006562 A MX2011006562 A MX 2011006562A MX 2011006562 A MX2011006562 A MX 2011006562A
- Authority
- MX
- Mexico
- Prior art keywords
- liposomes
- making small
- stream
- cooling
- mixture
- Prior art date
Links
- 239000002502 liposome Substances 0.000 title abstract 6
- 238000004519 manufacturing process Methods 0.000 title 1
- 238000001816 cooling Methods 0.000 abstract 2
- 239000000203 mixture Substances 0.000 abstract 2
- 239000003960 organic solvent Substances 0.000 abstract 2
- 239000002245 particle Substances 0.000 abstract 2
- XLYOFNOQVPJJNP-UHFFFAOYSA-N water Substances O XLYOFNOQVPJJNP-UHFFFAOYSA-N 0.000 abstract 2
- 150000002632 lipids Chemical class 0.000 abstract 1
- 238000002360 preparation method Methods 0.000 abstract 1
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07K—PEPTIDES
- C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
- C07K14/435—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
- C07K14/775—Apolipopeptides
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07F—ACYCLIC, CARBOCYCLIC OR HETEROCYCLIC COMPOUNDS CONTAINING ELEMENTS OTHER THAN CARBON, HYDROGEN, HALOGEN, OXYGEN, NITROGEN, SULFUR, SELENIUM OR TELLURIUM
- C07F9/00—Compounds containing elements of Groups 5 or 15 of the Periodic Table
- C07F9/02—Phosphorus compounds
- C07F9/06—Phosphorus compounds without P—C bonds
- C07F9/08—Esters of oxyacids of phosphorus
- C07F9/09—Esters of phosphoric acids
- C07F9/10—Phosphatides, e.g. lecithin
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/10—Dispersions; Emulsions
- A61K9/127—Synthetic bilayered vehicles, e.g. liposomes or liposomes with cholesterol as the only non-phosphatidyl surfactant
- A61K9/1277—Preparation processes; Proliposomes
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K38/00—Medicinal preparations containing peptides
- A61K38/16—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
- A61K38/17—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
- A61K38/1703—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans from vertebrates
- A61K38/1709—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans from vertebrates from mammals
- A61K38/1735—Mucins, e.g. human intestinal mucin
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K39/00—Medicinal preparations containing antigens or antibodies
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/10—Dispersions; Emulsions
- A61K9/127—Synthetic bilayered vehicles, e.g. liposomes or liposomes with cholesterol as the only non-phosphatidyl surfactant
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P37/00—Drugs for immunological or allergic disorders
- A61P37/02—Immunomodulators
- A61P37/04—Immunostimulants
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
Landscapes
- Health & Medical Sciences (AREA)
- Chemical & Material Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- General Health & Medical Sciences (AREA)
- Medicinal Chemistry (AREA)
- Pharmacology & Pharmacy (AREA)
- Animal Behavior & Ethology (AREA)
- Public Health (AREA)
- Veterinary Medicine (AREA)
- Epidemiology (AREA)
- Immunology (AREA)
- Organic Chemistry (AREA)
- Microbiology (AREA)
- Mycology (AREA)
- Dispersion Chemistry (AREA)
- Engineering & Computer Science (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Biochemistry (AREA)
- Molecular Biology (AREA)
- Proteomics, Peptides & Aminoacids (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Gastroenterology & Hepatology (AREA)
- Zoology (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- General Chemical & Material Sciences (AREA)
- Toxicology (AREA)
- Marine Sciences & Fisheries (AREA)
- Biophysics (AREA)
- Genetics & Genomics (AREA)
- Medicinal Preparation (AREA)
- Manufacturing Of Micro-Capsules (AREA)
- Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
- Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
- Peptides Or Proteins (AREA)
Applications Claiming Priority (2)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| US13835308P | 2008-12-17 | 2008-12-17 | |
| PCT/US2009/068499 WO2010078045A2 (en) | 2008-12-17 | 2009-12-17 | Method of making small liposomes |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| MX2011006562A true MX2011006562A (es) | 2011-09-27 |
Family
ID=42310550
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| MX2011006562A MX2011006562A (es) | 2008-12-17 | 2009-12-17 | Metodo para elaborar liposomas pequeños. |
Country Status (12)
| Country | Link |
|---|---|
| US (3) | US20120034294A1 (enExample) |
| EP (1) | EP2367532A4 (enExample) |
| JP (2) | JP2012512260A (enExample) |
| KR (1) | KR101452033B1 (enExample) |
| CN (2) | CN102256595A (enExample) |
| AU (1) | AU2009333177B2 (enExample) |
| BR (1) | BRPI0923001A2 (enExample) |
| CA (1) | CA2747182C (enExample) |
| EA (1) | EA020604B1 (enExample) |
| MX (1) | MX2011006562A (enExample) |
| SG (1) | SG172257A1 (enExample) |
| WO (1) | WO2010078045A2 (enExample) |
Families Citing this family (11)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| TWI395591B (zh) * | 2004-04-01 | 2013-05-11 | Oncothyreon Inc | 黏液性糖蛋白(muc-1)疫苗 |
| JP5771366B2 (ja) * | 2009-09-02 | 2015-08-26 | 株式会社バイオメッドコア | リポソーム製造装置及び方法 |
| KR20140023903A (ko) | 2011-02-24 | 2014-02-27 | 온코타이레온, 인코포레이티드 | 항원보강제를 갖는 muc1 기초 당지질펩티드 백신 |
| KR101387575B1 (ko) * | 2012-08-10 | 2014-04-23 | 서울대학교산학협력단 | 인지질 및 아세틸렌기를 포함하는 리포좀 및 그의 용도 |
| US9693958B2 (en) * | 2013-03-15 | 2017-07-04 | Cureport, Inc. | Methods and devices for preparation of lipid nanoparticles |
| AU2014329547B2 (en) * | 2013-10-02 | 2019-05-16 | The Board Of Trustees Of The Leland Stanford Junior University | Wnt compositions and methods for purification |
| CN107427791B (zh) * | 2015-03-19 | 2021-05-14 | 康涅狄格大学 | 用于连续制造脂质体药物制剂的系统和方法 |
| EP3610943B1 (en) * | 2017-04-13 | 2023-05-31 | National University Corporation Hokkaido University | Flow channel structure and lipid particle or micelle formation method using same |
| EP3711749A1 (en) * | 2019-03-19 | 2020-09-23 | Polymun Scientific Immunbiologische Forschung GmbH | Method of making lipid nanoparticles |
| US11737979B2 (en) | 2019-03-19 | 2023-08-29 | Arcturus Therapeutics, Inc. | Method of making lipid-encapsulated RNA nanoparticles |
| WO2023041588A1 (en) | 2021-09-14 | 2023-03-23 | Advapharm Gmbh | Novel lipopeptide formulation |
Family Cites Families (15)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| JPH11139961A (ja) * | 1997-11-06 | 1999-05-25 | Taisho Pharmaceut Co Ltd | リポソームの製造方法 |
| JP2002509102A (ja) * | 1998-01-16 | 2002-03-26 | バイオミラ・ユーエスエイ・インコーポレイテッド | リポマトリックス製剤 |
| AU771706B2 (en) * | 1999-07-15 | 2004-04-01 | University Of British Columbia, The | Methods and apparatus for preparation of lipid vesicles |
| WO2001036433A2 (en) * | 1999-11-15 | 2001-05-25 | Biomira, Inc. | Synthetic lipid-a analogs and uses thereof |
| EP1343476B1 (en) * | 2000-12-01 | 2008-05-28 | Biomira Inc. | Preparation of large liposomes by infusion into peg |
| US20030235610A1 (en) * | 2002-06-21 | 2003-12-25 | Piedmont Pharmaceuticals, Llc | Liposomes containing biologically active compounds |
| WO2004071638A2 (en) * | 2003-02-11 | 2004-08-26 | Regents Of The University Of California, The | Microfluidic devices and method for controlled viscous shearing and formation of amphiphilic vesicles |
| US9198645B2 (en) * | 2003-11-26 | 2015-12-01 | The United States of America, as represented by the Secretary of Commerce of The National Institute of Standards and Technology | Controlled vesicle self-assembly in continuous two phase flow microfluidic channels |
| TWI395591B (zh) * | 2004-04-01 | 2013-05-11 | Oncothyreon Inc | 黏液性糖蛋白(muc-1)疫苗 |
| CA2596131A1 (en) * | 2005-01-28 | 2006-08-03 | Bc Cancer Agency | Liposomal compositions for parenteral delivery of agents |
| ES2526344T3 (es) * | 2005-06-28 | 2015-01-09 | Oncothyreon Inc. | Método para el tratamiento de pacientes con una vacuna de glicoproteína mucinosa (MUC-1) |
| JP5639338B2 (ja) * | 2005-07-27 | 2014-12-10 | プロチバ バイオセラピューティクス インコーポレイティッド | リポソームの製造システムおよび製造方法 |
| EP2012750B1 (en) * | 2006-04-06 | 2018-02-21 | Insmed Incorporated | Methods for coacervation induced liposomal encapsulation and formulations thereof |
| US7811603B2 (en) * | 2006-05-09 | 2010-10-12 | The Regents Of The University Of California | Microfluidic device for forming monodisperse lipoplexes |
| JP5126874B2 (ja) * | 2007-05-21 | 2013-01-23 | 国立大学法人神戸大学 | リポソーム製剤の製造方法 |
-
2009
- 2009-12-17 BR BRPI0923001A patent/BRPI0923001A2/pt not_active IP Right Cessation
- 2009-12-17 KR KR1020117015492A patent/KR101452033B1/ko not_active Expired - Fee Related
- 2009-12-17 MX MX2011006562A patent/MX2011006562A/es active IP Right Grant
- 2009-12-17 JP JP2011542440A patent/JP2012512260A/ja active Pending
- 2009-12-17 CN CN2009801509533A patent/CN102256595A/zh active Pending
- 2009-12-17 EA EA201100829A patent/EA020604B1/ru not_active IP Right Cessation
- 2009-12-17 WO PCT/US2009/068499 patent/WO2010078045A2/en not_active Ceased
- 2009-12-17 EP EP09836955A patent/EP2367532A4/en not_active Withdrawn
- 2009-12-17 CN CN201610381865.6A patent/CN105935352A/zh active Pending
- 2009-12-17 US US13/140,786 patent/US20120034294A1/en not_active Abandoned
- 2009-12-17 SG SG2011044831A patent/SG172257A1/en unknown
- 2009-12-17 AU AU2009333177A patent/AU2009333177B2/en not_active Ceased
- 2009-12-17 CA CA2747182A patent/CA2747182C/en not_active Expired - Fee Related
-
2013
- 2013-03-13 US US13/799,324 patent/US20130330398A1/en not_active Abandoned
-
2014
- 2014-07-14 JP JP2014143840A patent/JP5895030B2/ja not_active Expired - Fee Related
-
2015
- 2015-05-12 US US14/710,484 patent/US20150315217A1/en not_active Abandoned
Also Published As
| Publication number | Publication date |
|---|---|
| EP2367532A4 (en) | 2012-12-12 |
| KR101452033B1 (ko) | 2014-10-21 |
| WO2010078045A2 (en) | 2010-07-08 |
| EP2367532A2 (en) | 2011-09-28 |
| CN105935352A (zh) | 2016-09-14 |
| BRPI0923001A2 (pt) | 2018-09-18 |
| US20120034294A1 (en) | 2012-02-09 |
| WO2010078045A3 (en) | 2010-10-28 |
| CA2747182A1 (en) | 2010-07-08 |
| CN102256595A (zh) | 2011-11-23 |
| JP2012512260A (ja) | 2012-05-31 |
| SG172257A1 (en) | 2011-07-28 |
| JP5895030B2 (ja) | 2016-03-30 |
| US20150315217A1 (en) | 2015-11-05 |
| AU2009333177A1 (en) | 2011-07-07 |
| KR20110094114A (ko) | 2011-08-19 |
| JP2014224127A (ja) | 2014-12-04 |
| CA2747182C (en) | 2014-11-18 |
| EA201100829A1 (ru) | 2012-02-28 |
| EA020604B1 (ru) | 2014-12-30 |
| US20130330398A1 (en) | 2013-12-12 |
| AU2009333177B2 (en) | 2013-09-19 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| MX2011006562A (es) | Metodo para elaborar liposomas pequeños. | |
| WO2010078833A8 (zh) | 一种改性钠基蒙脱石、其制备方法和用途 | |
| CA3047846C (en) | Method and system for synthesizing fuel from dilute carbon dioxide source | |
| WO2008154257A3 (en) | Methods and apparatuses for ammonia production | |
| JP2013529781A5 (enExample) | ||
| MX2011009235A (es) | Composiciones compuestas acuosas estables. | |
| WO2010042652A3 (en) | Heteroalkyl biphenyl antagonists of prostaglandin d2 receptors | |
| EP1905802A3 (en) | Organic pigment fine particles and method of producing the same | |
| MY161727A (en) | Lng facility employing a heavies enriching stream | |
| WO2010075856A3 (de) | Verfahren zur abkühlung der troposphäre | |
| EA201270402A1 (ru) | Способ получения гранул | |
| WO2008084828A1 (ja) | 補酵素q10粒子の製造方法 | |
| CY1114610T1 (el) | Μεθοδος παραγωγης ενος συνδυασμενου ρευματος συστατικων αεριων υδρογονανθρακων καθως και ρευματων συστατικων υγρων υδρογονανθρακων και εξοπλισμος για αυτην | |
| WO2017005096A3 (zh) | 一种多路视频流的编码方法及装置 | |
| EP2259145A3 (en) | Toner process including modifying rheology | |
| WO2009007992A8 (en) | Pharmaceutical composition produced by microprecipitation | |
| WO2009027937A3 (en) | Clustered magnetic particles as tracers for magnetic particle imaging | |
| MX2014002994A (es) | Metodo y aparato para la produccion dinamica de una mezcla de gases. | |
| MY169923A (en) | Flame-proofed polyamides with light colouring | |
| WO2009016579A3 (en) | Method for the preparation of a hydrocarbon synthesis catalyst and the use thereof in a hydrocarbon synthesis process | |
| WO2009078293A1 (ja) | 液体材料気化装置 | |
| GB201310135D0 (en) | Method and system for providing purified water | |
| WO2011124589A3 (de) | Verfahren und vorrichtungen zur vesikelbildung, insbesondere unter verwendung von block-copolymeren | |
| MX2024004733A (es) | Metodos de alto rendimiento para preparar nanoparticulas lipidicas y sus usos. | |
| WO2012177097A3 (en) | Method of fabricating silicon carbide powder |
Legal Events
| Date | Code | Title | Description |
|---|---|---|---|
| FG | Grant or registration |